Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-11-01, Stock:LLY, The news for the past five days is as follows:
2021-10-25: NEWS1: Cramer: ‘Stop freaking out’ about inflation — here's how to profit from soaring costs.
2021-10-26: NEWS1: Eli Lilly and Company (LLY) Q3 2021 Earnings Call Transcript.NEWS2: Eli Lilly Earnings Disappointed. Why the Stock Is Rising..NEWS3: Eli Lilly Earnings Missed Estimates. Here’s Why the Stock Is Rising..NEWS4: The Eli Lilly-Biogen Clash In Alzheimer's Begins — How Will It Play Out?.NEWS5: Eli Lilly Is Asking the FDA to Approve Its Alzheimer’s Therapy.NEWS6: Eli Lilly Asks FDA to Approve Alzheimer’s Drug.NEWS7: Hasbro warns supply chain bottlenecks, Sherwin-Williams cuts guidance on inflation fears, Lilly raises 2021 outlook.NEWS8: Eli Lilly (LLY) Q3 Earnings Miss, COVID Drugs Drive Sales.NEWS9: Home Prices Stay "Lofty;" UPS Beats, Lilly Mixed.NEWS10: Eli Lilly Stock Gains After2021 Outlook Lift Following Q3 Earnings.NEWS11: Eli Lilly Posts Mixed Third Quarter, But Raises 2021 Sales Guidance.NEWS12: Eli Lilly Q3 Earnings Beat Estimates, Boosts FY21 Guidance On Higher COVID-19 Therapy Sales.NEWS13: The Daily Biotech Pulse: Moderna Gains On Vaccine News, Novartis Reports Q3 Beat, Adcom Reviews Authorization Of Pfizer-BioNTech's Vaccine For Children.NEWS14: Lilly plans to run clinical trial comparing its Alzheimer's drug candidate to Biogen's Aduhelm.NEWS15: Eli Lilly (LLY) Misses Q3 Earnings Estimates.NEWS16: UPDATE 5-Lilly kicks off application for Alzheimer's drug U.S. approval.NEWS17: Eli Lilly & Co. net income falls 8%, but adjusted profit rises.NEWS18: Eli Lilly Misses Profit Estimates but Boosts Guidance. The Stock Is Rising..NEWS19: Lilly kicks off application for Alzheimer's drug U.S. approval.NEWS20: Lilly Reports Robust Third-Quarter 2021 Financial Results as Pipeline Success Strengthens Future Growth Potential.NEWS21: Eli Lilly Stock Slides On Q3 Earnings Miss, COVID Therapy Sales Outlook.NEWS22: Eli Lilly Stock Gains After 2021 Outlook Boost Offsets Q3 Earnings Miss.NEWS23: Facebook, Uber, UPS and General Electric Rise Premarket.NEWS24: Eli Lilly Stock Jumps After 2021 Outlook Boost Offsets Q3 Earnings Miss.
2021-10-27: NEWS1: 10 Stocks Making Noise After Releasing Their Earnings Reports.NEWS2: Healthcare ETFs in Focus as Q3 Earnings Unfold.NEWS3: Stock Market News for Oct 27, 2021.NEWS4: Eli Lilly Pitches Alzheimer Drug to the FDA, Aiming to Leapfrog Biogen.
2021-10-28: NEWS1: Additional Verzenio® (abemaciclib) Phase 3 monarchE Trial Data Published in the Annals of Oncology.NEWS2: Down 76%: Is Cortexyme Stock a Bargain?.NEWS3: Inventiva Plans To Start Lanifibranor Combo Study In NASH, Diabetes In 2022.NEWS4: Cortexyme's Alzheimer's Drug Fails -- 2 Lessons for Investors.
2021-10-29: NEWS1: CEO details plan for gene therapy firm's $125M RTP expansion.NEWS2: Top Research Reports for Alphabet, Eli Lilly & Sony.NEWS3: Pharma Stock Roundup: Big Pharma Q3 Results, FDA Panel's Vote for PFE COVID Jab.NEWS4: Why Eli Lilly and Company (NYSE:LLY) may be Cheap and has Growth Driven by Capital Investments.

Answer: Decrease